Esomeprazole Capsules 40mg
Gastroesophageal reflux (reflux esophagitis, long-term preventive treatment for relapse of healed esophagitis, symptomatic treatment of gastroesophageal reflux). In peptic and duodenal ulcer, in combination for eradicating Helicobacter pylori (healing of Helicobacter pylori-induced duodenal ulcer, prevention of peptic ulcer relapse in patients with Helicobacter pylori-related ulcers). Other investigated uses: Management of Zollinger-Ellison syndrome. Short-term treatment (4-8 weeks) of erosive esophagitis; maintenance of symptom resolution and healing of erosive esophagitis; treatment of symptomatic gastroesophageal reflux disease; as part of a multidrug regimen for Helicobacter pylori eradication in patients with duodenal ulcer (active or history of disease in the last 5 years).
Pharmaceutical form
Capsule
Concentration
40mg
Combination
N/A
Disclaimer: The content of this website is for pharmaceutical industry professionals interested in creating a strategic alliance with Wexford Laboratories. This page may contain information related to health, medical conditions, physical condition and its treatment. The information contained in this site is not to diagnose a health problem and is not a substitute for the advice provided by your doctor. Always consult a doctor when in doubt about a disease and its treatment. The products are subject to the applicable patent and registration laws of each country, and may not be allowed to be registered in some markets.
